Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus + trastuzumab + paclitaxel in women (Japan)
jRCT2080220953Phase 3Completed
- Start
- Jan 2010
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 3 trial of everolimus, trastuzumab and paclitaxel in breast cancer. Started Jan 2010; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on jRCT2080220953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220953.